STERIS plc (NYSE:STE) Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC increased its stake in shares of STERIS plc (NYSE:STE) by 93.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 82,604 shares of the medical equipment provider’s stock after purchasing an additional 39,894 shares during the period. Hsbc Holdings PLC’s holdings in STERIS were worth $16,946,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Franklin Resources Inc. increased its stake in STERIS by 171.2% during the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after buying an additional 529,308 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in shares of STERIS by 30.8% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider’s stock worth $2,275,000 after purchasing an additional 2,583 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in STERIS in the 3rd quarter valued at $9,949,000. Merit Financial Group LLC purchased a new position in STERIS in the 4th quarter valued at $260,000. Finally, Blue Trust Inc. boosted its stake in STERIS by 19.9% during the 4th quarter. Blue Trust Inc. now owns 1,128 shares of the medical equipment provider’s stock worth $232,000 after purchasing an additional 187 shares during the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

STE has been the subject of a number of recent research reports. JMP Securities reiterated a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, April 10th. Stephens reissued an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Monday, April 7th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Stock Down 0.6 %

Shares of STE opened at $225.00 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The firm has a market cap of $22.11 billion, a P/E ratio of 47.77 and a beta of 0.87. The company’s 50-day moving average price is $222.89 and its 200 day moving average price is $218.90. STERIS plc has a 12-month low of $200.98 and a 12-month high of $248.24.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, sell-side analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were paid a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. STERIS’s dividend payout ratio (DPR) is 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.